Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Grifoni

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
Vaccine|April 18, 2026
Chikungunya virus virus-like particle vaccine (Vimkunya) induces a rapid and durable antigen-specific CD4<sup>+</sup> T cell responseFernanda H Cortes, Rimjhim Agarwal, Calvin Ha, et al.
Human Immunology|October 3, 2018
Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USAEugene Moore, Alba Grifoni, Daniela Weiskopf, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
The Journal of Infectious Diseases|March 13, 2024
Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIVEva Grüner, Marica Grossegesse, Daniel Stern, et al.
Cell|October 23, 2020
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup>+</sup> T Cells in COVID-19Benjamin J Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 24, 2022
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseasesLinda Petrone, Andrea Picchianti-Diamanti, Gian Domenico Sebastiani, et al.
Viruses|January 22, 2022
A Population of CD4<sup>+</sup>CD8<sup>+</sup> Double-Positive T Cells Associated with Risk of Plasma Leakage in Dengue Viral InfectionEsther Dawen Yu, Hao Wang, Ricardo da Silva Antunes, et al.
Cell Reports. Medicine|May 21, 2025
Chikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humansRimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.
Ebiomedicine|May 26, 2022
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trialZoltán Bánki, Jose Mateus, Annika Rössler, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
Vaccine|April 18, 2026
Chikungunya virus virus-like particle vaccine (Vimkunya) induces a rapid and durable antigen-specific CD4<sup>+</sup> T cell responseFernanda H Cortes, Rimjhim Agarwal, Calvin Ha, et al.
Human Immunology|October 3, 2018
Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USAEugene Moore, Alba Grifoni, Daniela Weiskopf, et al.
JAMA Neurology|February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With OcrelizumabNatacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
The Journal of Infectious Diseases|March 13, 2024
Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIVEva Grüner, Marica Grossegesse, Daniel Stern, et al.
Cell|October 23, 2020
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup>+</sup> T Cells in COVID-19Benjamin J Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyNatacha Madelon, Kim Lauper, Gautier Breville, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 24, 2022
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseasesLinda Petrone, Andrea Picchianti-Diamanti, Gian Domenico Sebastiani, et al.
Viruses|January 22, 2022
A Population of CD4<sup>+</sup>CD8<sup>+</sup> Double-Positive T Cells Associated with Risk of Plasma Leakage in Dengue Viral InfectionEsther Dawen Yu, Hao Wang, Ricardo da Silva Antunes, et al.
Cell Reports. Medicine|May 21, 2025
Chikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humansRimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.
Ebiomedicine|May 26, 2022
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trialZoltán Bánki, Jose Mateus, Annika Rössler, et al.
Pageof 21